1. Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential. (6th May 2015) Authors: Flood, B; Oficjalska, K; Laukens, D; Fay, J; O'Grady, A; Caiazza, F; Heetun, Z; Mills, K H G; Sheahan, K; Ryan, E J; Doherty, G A; Kay, E; Creagh, E M Journal: Clinical and experimental immunology Issue: Volume 181:Number 1(2015:Jul.) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AWARENESS OF ADVERSE EFFECTS OF AZATHIOPRINE AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE. (8th June 2013) Authors: Spence, A D; Lee, R; Keegan, D; Doherty, G A; Mulcahy, H; O'Donoghue, D; Murphy, S J Journal: Gut Issue: Volume 62(2013)Supplement 2 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IS AVAILABILITY OF MR ENTEROGRAPHY (MRE) REDUCING AVOIDABLE USE OF IONISING RADIATION IN DIAGNOSTIC IMAGING FOR CROHN'S DISEASE?. (8th June 2013) Authors: Smyth, A E; Gibson, D J; Murphy, D J; Keegan, D; Cullen, G; Mulcahy, H E; Malone, D; Doherty, G A Journal: Gut Issue: Volume 62(2013)Supplement 2 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐Term Safety ofIn UteroExposure to Anti‐TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. (March 2018) Authors: Chaparro, M; Verreth, A; Lobaton, T; Gravito‐Soares, E; Julsgaard, M; Savarino, E; Magro, F; Biron, Avni I; Lopez‐Serrano, P; Casanova, M J; Gompertz, M; Vitor, S; Arroyo, M; Pugliese, D; Zabana, Y; Vicente, R; Aguas, M; Shitrit, Bar‐Gil A; Gutierrez, A; Doherty, G A Journal: American journal of gastroenterology Issue: Volume 113:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2. Issue 12 (26th January 2008) Authors: Molloy, E S; Morgan, M P; Doherty, G A; McDonnell, B; O'Byrne, J; Fitzgerald, D J; McCarthy, G M Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 12(2008) Page Start: 1773 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OPTIMISING SCREENING FOR OPPORTUNISTIC INFECTION PRIOR TO ANTI-TNF THERAPY. (8th June 2013) Authors: Judge, C; DeGascun, C; Keegan, D; Byrne, K; Mulcahy, H E; Cullen, G; Doherty, G A Journal: Gut Issue: Volume 62(2013)Supplement 2 Page Start: A41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P022 Severe disease activity in UC is associated with mucosal hypoxia measured endoscopically. (16th January 2018) Authors: Rowan, C R; Brown, E; Ryan, E; Taylor, C; Doherty, G A Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P401 Association between induction vedolizumab drug levels and therapy outcome in inflammatory bowel disease. (25th January 2019) Authors: O'Connell, J; Ismail, M S; McCormack, M; McDonagh, P; Argue, R; Breslin, N; Crowley, V; Cullen, G; Doherty, G A; Dunne, C; Hartery, K; MacCarthy, F; McKiernan, S; Mulcahy, H; O'Connor, A; O'Morain, C; Ryan, B; Sheridan, J; Healy, M; McNamara, D Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P405 Sustainability of biologic therapies is less in UC than CD patients independent of prior biologic experience. (25th January 2019) Authors: Doherty, J; Buckley, M; Cullen, G; Keegan, D; Byrne, K; Horgan, G; Mulcahy, H; Sheridan, J; Doherty, G A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P481 Induction treatment with subcutaneous rather than intravenous ustekinumab is associated with comparable circulating drugs levels and early clinical response. (16th January 2018) Authors: Rowan, C R; Cullen, G; Mulcahy, H; Sheridan, J; Ryan, E; De Vries, A; D'Haens, G; Doherty, G A Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗